PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Tekla Healthcare Investors (HQH)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US87911J1034

CUSIP

87911J103

Sector

Financial Services

IPO Date

Jan 5, 1988

Highlights

Market Cap

$877.35M

EPS (TTM)

$3.53

PE Ratio

4.77

Total Revenue (TTM)

$5.31M

Gross Profit (TTM)

$5.31M

EBITDA (TTM)

$149.56M

Year Range

$14.17 - $18.57

Short Ratio

1.17

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
HQH vs. RQI HQH vs. XLV HQH vs. USA HQH vs. SPY HQH vs. NOBL HQH vs. VOO HQH vs. JEPI HQH vs. ARCC HQH vs. DX HQH vs. VUG
Popular comparisons:
HQH vs. RQI HQH vs. XLV HQH vs. USA HQH vs. SPY HQH vs. NOBL HQH vs. VOO HQH vs. JEPI HQH vs. ARCC HQH vs. DX HQH vs. VUG

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Tekla Healthcare Investors, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


2,000.00%3,000.00%4,000.00%5,000.00%JulyAugustSeptemberOctoberNovemberDecember
4,543.67%
2,193.18%
HQH (Tekla Healthcare Investors)
Benchmark (^GSPC)

Returns By Period

Tekla Healthcare Investors had a return of 11.87% year-to-date (YTD) and 14.50% in the last 12 months. Over the past 10 years, Tekla Healthcare Investors had an annualized return of 3.05%, while the S&P 500 had an annualized return of 11.06%, indicating that Tekla Healthcare Investors did not perform as well as the benchmark.


HQH

YTD

11.87%

1M

-4.74%

6M

2.98%

1Y

14.50%

5Y*

4.49%

10Y*

3.05%

^GSPC (Benchmark)

YTD

24.34%

1M

0.23%

6M

8.53%

1Y

24.95%

5Y*

13.01%

10Y*

11.06%

Monthly Returns

The table below presents the monthly returns of HQH, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20243.38%0.97%0.24%-4.21%6.15%5.44%6.36%5.27%-1.74%-3.17%0.18%11.87%
20235.67%-3.29%-1.84%-1.36%-1.47%1.73%0.06%-0.59%-6.10%-6.05%4.64%11.13%1.22%
2022-5.01%-9.13%3.80%-2.79%-0.86%-4.50%3.37%-1.77%-7.10%8.51%4.43%-6.15%-17.27%
20210.04%6.81%-2.20%1.84%0.67%4.94%0.89%5.00%-4.41%2.15%-5.42%-1.82%7.99%
2020-3.88%-3.28%-6.11%14.43%6.16%0.52%-1.22%3.38%-3.10%-4.02%12.68%9.44%24.82%
201917.44%-0.73%0.10%-3.80%-2.37%6.53%-1.79%-2.74%-2.08%5.83%8.18%1.41%26.80%
20184.21%-2.76%-3.80%-3.07%4.13%1.13%3.77%6.09%-0.17%-11.02%3.25%-13.49%-13.08%
20177.24%9.63%-1.39%5.16%-3.43%4.98%2.51%1.29%-1.14%-6.66%-2.05%0.04%16.06%
2016-19.66%-1.83%5.31%3.92%5.64%-9.25%11.26%-4.53%-2.66%-11.84%11.20%-7.53%-22.44%
20157.27%6.03%-0.97%-3.50%9.14%-1.33%3.10%-7.81%-16.39%19.31%-3.60%-1.86%5.00%
20140.33%13.21%-9.66%-2.35%0.07%1.03%3.91%5.39%0.32%6.97%9.41%-3.46%25.73%
201310.86%1.60%4.44%9.91%3.88%2.64%7.09%-5.24%4.72%2.25%8.35%3.53%68.02%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of HQH is 74, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of HQH is 7474
Overall Rank
The Sharpe Ratio Rank of HQH is 7979
Sharpe Ratio Rank
The Sortino Ratio Rank of HQH is 7272
Sortino Ratio Rank
The Omega Ratio Rank of HQH is 7070
Omega Ratio Rank
The Calmar Ratio Rank of HQH is 7171
Calmar Ratio Rank
The Martin Ratio Rank of HQH is 7979
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Tekla Healthcare Investors (HQH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for HQH, currently valued at 0.99, compared to the broader market-4.00-2.000.002.000.992.10
The chart of Sortino ratio for HQH, currently valued at 1.44, compared to the broader market-4.00-2.000.002.004.001.442.80
The chart of Omega ratio for HQH, currently valued at 1.19, compared to the broader market0.501.001.502.001.191.39
The chart of Calmar ratio for HQH, currently valued at 0.56, compared to the broader market0.002.004.006.000.563.09
The chart of Martin ratio for HQH, currently valued at 4.22, compared to the broader market-5.000.005.0010.0015.0020.0025.004.2213.49
HQH
^GSPC

The current Tekla Healthcare Investors Sharpe ratio is 0.99. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Tekla Healthcare Investors with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio1.001.502.002.503.003.50JulyAugustSeptemberOctoberNovemberDecember
0.99
2.10
HQH (Tekla Healthcare Investors)
Benchmark (^GSPC)

Dividends

Dividend History

Tekla Healthcare Investors provided a 14.00% dividend yield over the last twelve months, with an annual payout of $2.28 per share.


6.00%7.00%8.00%9.00%10.00%11.00%12.00%$0.00$1.00$2.00$3.00$4.0020132014201520162017201820192020202120222023
Dividends
Dividend Yield
PeriodTTM20232022202120202019201820172016201520142013
Dividend$2.28$1.60$1.71$2.04$1.90$1.72$1.93$1.98$2.07$3.55$2.22$1.73

Dividend yield

14.00%9.66%9.50%8.59%7.97%8.24%10.75%8.78%9.80%11.97%7.05%6.41%

Monthly Dividends

The table displays the monthly dividend distributions for Tekla Healthcare Investors. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.00$0.48$0.00$0.00$0.59$0.00$0.00$0.59$0.00$0.00$0.62$0.00$2.28
2023$0.00$0.42$0.00$0.00$0.40$0.00$0.00$0.40$0.00$0.00$0.38$0.00$1.60
2022$0.00$0.48$0.00$0.00$0.44$0.00$0.00$0.40$0.00$0.00$0.39$0.00$1.71
2021$0.00$0.51$0.00$0.00$0.50$0.00$0.00$0.52$0.00$0.00$0.51$0.00$2.04
2020$0.00$0.47$0.00$0.00$0.41$0.00$0.00$0.49$0.00$0.00$0.48$0.05$1.90
2019$0.00$0.41$0.00$0.00$0.45$0.00$0.00$0.45$0.00$0.00$0.41$0.00$1.72
2018$0.00$0.48$0.00$0.00$0.47$0.00$0.00$0.47$0.00$0.00$0.51$0.00$1.93
2017$0.00$0.45$0.00$0.00$0.50$0.00$0.00$0.51$0.00$0.00$0.52$0.00$1.98
2016$0.00$0.61$0.00$0.00$0.49$0.00$0.00$0.47$0.00$0.00$0.50$0.00$2.07
2015$0.00$0.63$0.00$0.00$0.68$0.00$0.00$0.71$0.00$0.00$0.59$0.94$3.55
2014$0.00$0.53$0.00$0.00$0.54$0.00$0.00$0.56$0.00$0.00$0.59$0.00$2.22
2013$0.37$0.00$0.00$0.42$0.00$0.00$0.44$0.00$0.00$0.50$0.00$1.73

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%14.0%
Tekla Healthcare Investors has a dividend yield of 14.00%, which means its dividend payment is significantly above the market average.
Payout Ratio
200.0%400.0%600.0%800.0%126.7%
Tekla Healthcare Investors has a payout ratio of 126.72%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-20.00%-15.00%-10.00%-5.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-17.11%
-2.62%
HQH (Tekla Healthcare Investors)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Tekla Healthcare Investors. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Tekla Healthcare Investors was 56.17%, occurring on Dec 8, 1994. Recovery took 1273 trading sessions.

The current Tekla Healthcare Investors drawdown is 17.11%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-56.17%Jan 10, 1992738Dec 8, 19941273Dec 23, 19992011
-53.33%Feb 18, 2000662Oct 9, 20021094Feb 14, 20071756
-45.25%Aug 18, 2008140Mar 9, 2009469Jan 14, 2011609
-41.83%Jul 20, 2015144Feb 11, 20161226Dec 23, 20201370
-37.55%Aug 26, 2021547Oct 27, 2023

Volatility

Volatility Chart

The current Tekla Healthcare Investors volatility is 5.05%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%JulyAugustSeptemberOctoberNovemberDecember
5.05%
3.79%
HQH (Tekla Healthcare Investors)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Tekla Healthcare Investors over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Tekla Healthcare Investors compared to its peers in the Asset Management industry.


PE Ratio
100.0200.0300.04.8
The chart displays the price to earnings (P/E) ratio for HQH in comparison to other companies of the Asset Management industry. Currently, HQH has a PE value of 4.8. This PE value is considered to be low compared to the rest of the industry.
PEG Ratio
-4.0-2.00.02.04.00.0
The chart displays the price to earnings to growth (PEG) ratio for HQH in comparison to other companies of the Asset Management industry. Currently, HQH has a PEG value of 0.0. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Tekla Healthcare Investors.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab